Graduate Management Admission Council Announces Two New Board Members and Incoming Chairperson of the Board
Leaders from Berkeley, Duke & Emory business schools bring additional depth and expertise to the organization
RESTON, Va., June 05, 2018 (GLOBE NEWSWIRE) -- The Graduate Management Admission Council (GMAC), a non-profit association of leading global business schools, is pleased to announce two additions to its board of directors and announce the new chairperson of the board. The terms for the new board directors begin on July 1, 2018; the chair position also takes effect as of July 1.
Dr. Bill Boulding, dean of Duke University's Fuqua School of Business, will chair the board. New board members are Erika James, John H. Harland dean of Goizueta Business School, Emory University, and Peter Johnson, assistant dean, full-time MBA Program and admissions, Haas School of Business at the University of California, Berkeley. The term for the board chairperson is two years, four years for board members.
Dr. William "Bill" Boulding is dean of Duke University's Fuqua School of Business. Previously, he held several roles within the school including deputy dean and senior associate dean for programs and associate dean for the Daytime (full-time) MBA program. Dr. Boulding has a passion for helping advance business as a force for good. He served as a member of the World Economic Forum's Council on Values. It has been a privilege for Dr. Boulding to serve, at the invitation of the White House, in developing best practices for how business schools can encourage success for women and working families as part of an initiative with the White House Council on Women and Girls and the Council of Economic Advisers.
"It will be an honor to serve as the chairman of GMAC," said Boulding. "We are in a time of great disruption and transformation in graduate business education. It is essential we maintain relevancy for the world we live in today and I'm excited about the innovations ahead for the industry. I firmly believe in the power of business education in developing leaders who can use business to transform the world for the better."
Erika James became the John H. Harland dean of Goizueta Business School at Emory University in July 2014. A published researcher and award-winning educator with a passion for consulting and speaking, she places an emphasis on what higher education can do to be of service to industry. James is committed to advancing GMAC's mission with a keen interest in providing solutions for schools and candidates to discover and evaluate one another. James believes the success of a student's business education experience depends heavily on finding the right school for them and looks forward to working on the board to further this work. Under James' leadership, Goizueta remains one of the top business schools in the nation with an upward trajectory in student career success and faculty thought leadership. As an educator, James has been instrumental in starting various Executive Education programs, including the Women's Leadership program at Darden Graduate School of Business. James is committed to establishing an equal playing field across gender and race and, in 2014, was honored by the National Diversity Council.
"I'm thrilled to join the GMAC board of directors," said James. "Business, as a field and idea, can do so much more to advance society. GMAC is in the perfect position to influence the future of business education for good and I'm eager to have a role in shaping policy and public opinion with so many great leaders."
Peter Johnson became assistant dean, full-time MBA program and admissions of the Haas School of Business at the University of California, Berkeley, in June 2016. Johnson previously served in Berkeley MBA Admissions for 11 years, first as associate director (1999-2001), then as director of international admissions (2001-2006), and finally as executive director of MBA Admissions from February 2006 until August 2010, when he moved to Europe to serve as vice president for student services at Central European University in Budapest. Johnson returned to Berkeley as assistant dean of the Haas School in 2016, overseeing academics, student experience, and admissions for the Full-time MBA Program.
Johnson understands the changing needs and priorities of the industry and looks forward to working with the other board members to help address these current challenges. During his time at Haas, he developed and implemented strategy for recruiting applicants worldwide, managed application review and evaluations process for more than 4,000 applicants annually, developed and maintained alumni and student volunteer networks, and worked to diversify the school's recruitment efforts.
"I'm excited about serving on the GMAC Board at a time of significant change in higher education," said Johnson. "GMAC serves an important role in providing data and platforms for business schools across the globe to work together to share best practices for delivering effective and relevant business education aimed at developing leaders. It's also helped to address issues of access and equity in graduate management education. I look forward to working with fellow board members to help GMAC continue to evolve and provide value to business schools and business students around the world."
"GMAC relies on its board members to bring unequaled leadership and relevant experience to our organization and our mission," said Sangeet Chowfla, president and CEO of GMAC. "It is extremely gratifying to have such high caliber members of our industry engaged in the work we do to create solutions for schools and candidates, and help more people experience the life-changing benefits of graduate management education."
GMAC would like to thank outgoing board chair, Kate Klepper, associate dean, Graduate Business Programs, D'Amore-McKim School of Business, Northeastern University, whose term as board chair and board member ends June 30. Klepper's experience as chairperson has guided the organization over the past year as we have grown our assessments portfolio and created greater opportunities for candidates and schools to connect. Klepper is passionate about membership engagement and has led the Membership Committee of the board.
Also leaving the board as of June 30 are Jim Brady, Chief Operating Officer, Grant Thornton LLP, and Ken Freeman, Allen Questrom Professor & Dean, Questrom School of Business, Boston University. GMAC thanks them for their service to our organization and contributions to the education community.
About GMAC: The Graduate Management Admission Council (GMAC) is a global, non-profit association of leading graduate business schools. Founded in 1953, we are committed to creating solutions for business schools and candidates to better discover, evaluate and connect with each other. We work on behalf of the schools and the graduate management education community, as well as guide candidates on their journey to higher education, to ensure that no talent goes undiscovered.
GMAC provides world-class research, professional development opportunities and assessments for the industry, designed to advance the art and science of admissions. Owned and administered by GMAC, the Graduate Management Admission Test® (GMAT®) is the most widely used graduate business school assessment, recognized by more than 7,000 programs worldwide. Other GMAC assessments include the NMAT by GMAC(TM) exam, for entrance into graduate management programs in India and South Africa, and the Executive Assessment, specifically designed for Executive programs around the world. Our flagship portal for graduate management education resources and information, www.mba.com, receives 14 million visits a year and features the School Finder search tool and Graduate Management Admission Search Service (GMASS), matching candidates and business schools.
GMAC is based in the United States with offices in the United Kingdom, India, and Hong Kong. To learn more about our work, please visit www.gmac.com.
For information on GMAC's current board members, visit https://www.gmac.com/about-us/board-of-directors.aspx.
Sr. Director, Corporate Brand Communications
+1 (703) 668-9638 Office
+1 (571) 294-4059 Mobile
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Graduate Management Admission Council via Globenewswire
Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.
Senaste pressmeddelandena från GlobeNewswire
Karolinska Development delays publication of its Annual Report for 2018 and changes date for the Annual General Meeting26.4.2019 08:00:00 CEST | Pressmeddelande
STOCKHOLM, SWEDEN - 26 April 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that The Board of Directors has decided to delay the publication of its Annual Report for 2018. Karolinska Development has changed the date for the Annual General Meeting to June 26, 2019. The date for publication of the Annual Report for 2018 has been changed from April 26 to April 30, 2019. Karolinska Development has changed the date for the Annual General Meeting from June 4 to June 26, 2019. Notice to the Annual General Meeting will be published in a separate press release. For more information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: firstname.lastname@example.org Fredrik Järrsten, CFO, Karolinska Development AB Phone: +46 70 496 46 28, e-mail: email@example.com TO THE EDITORS About Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investmen
Karolinska Development senarelägger publicering av årsredovisningen för 2018 och meddelar nytt datum för årsstämma26.4.2019 08:00:00 CEST | Pressmeddelande
STOCKHOLM, SVERIGE - 26 april 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att styrelsen har beslutat att senarelägga publiceringen av årsredovisningen för 2018. Karolinska Development har ändrat datum för årsstämman till den 26 juni 2019. Publiceringen av årsredovisningen för 2018 flyttas från den 26 april till den 30 april 2019. Karolinska Development har ändrat datum för årsstämman från den 4 juni till den 26 juni 2019. Kallelse till årsstämman kommer att publiceras senare i ett separat pressmeddelande. För ytterligare information, vänligen kontakta: Viktor Drvota, vd, Karolinska Development AB Tel: +46 73 982 52 02, e-mail: firstname.lastname@example.org Fredrik Järrsten, finanschef, Karolinska Development AB Tel: +46 70 496 46 28, e-mail: email@example.com TILL REDAKTÖRERNA Om Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) är ett nordiskt investmentbolag inom life science. Bolaget fokuserar p
Karolinska Developments portföljbolag Aprea Therapeutics har fått särläkemedelsstatus och snabbspårstatus från FDA för APR-24616.4.2019 12:46:00 CEST | Pressmeddelande
STOCKHOLM, SVERIGE - 16 april 2019. Karolinska Development AB meddelar idag att portföljbolaget Aprea Therapeutics har av FDA fått särläkemedelsstatus för APR-246 för behandling av patienter med TP53-muterad myelodysplastiskt syndrom (MDS). Dessutom ger FDA bolaget snabbspårstatus (Fast Track Designation), för APR-246 för behandling av MDS. Amerikanska läkemedelsverket, FDA, ger särläkemedelsstatus till läkemedelskandidater för att snabba på utvärderingen och utvecklingen av säkra och effektiva behandlingar av ovanliga sjukdomar. Särläkemedelsstatus ger företag både regulatoriska och kommersiella incitament genom att läkemedlet får marknadsexklusivitet på den amerikanska marknaden i sju år efter marknadsgodkännande samtidigt som företaget får stöd från FDA när det gäller designen av kliniska prövningar, skatteförmåner för kostnader kopplade till kliniska prövningar och avgiftsbefrielse från FDA. FDA:s snabbspår underlättar utvecklingen av läkemedel som är avsedda för att behandla allva
Karolinska Development's portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-24616.4.2019 12:46:00 CEST | Pressmeddelande
STOCKHOLM, April 16, 2019. Karolinska Development's portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes (MDS) having a TP53 mutation. In addition, FDA has also granted Fast Track Designation to APR-246 for treatment of MDS. Orphan Drug Designation is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. after product approval, FDA assistance in clinical trial design, tax credits related to clinical trial expenses, and an exemption from FDA user fees. The FDA's Fast Track program facilitates the development of drugs intended to treat serious conditions and that have the potential to addre
Bergman & Beving AB: Bergman & Beving förvärvar KGC10.4.2019 14:00:00 CEST | Pressmeddelande
Pressmeddelande Bergman & Beving förvärvar KGC Bergman & Beving har idag tecknat avtal om förvärv av samtliga aktier i KGC Verktyg & Maskiner AB. KGC, med säte i Älvsjö, har i mer än 60 år utvecklat och levererat kvalitetsverktyg och tillbehör för murning och plattsättning i det egna varumärket KGC. Bolaget omsätter cirka 80 MSEK per år, och har 24 anställda. "KGC är ett ledande varumärke med högt anseende hos murare och plattsättare och har en mycket stark ställning på den svenska marknaden", säger Pontus Boman, VD och koncernchef. Tillträde beräknas ske den 1 maj 2019 och förvärvet bedöms ha en marginellt positiv påverkan på Bergman & Bevings resultat per aktie under innevarande räkenskapsår. Stockholm den 10 april 2019 Bergman & Beving AB (publ) För ytterligare information kontakta: Pontus Boman, VD & Koncernchef, telefon 010-454 77 00 Peter Schön, CFO, telefon 070-339 89 99 Denna information lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 10 april 201
Bergman & Beving AB: Bergman & Beving acquires KGC10.4.2019 14:00:00 CEST | Pressmeddelande
Press release Bergman & Beving acquires KGC Bergman & Beving has today signed an agreement to acquire all shares in KGC Verktyg & Maskiner AB. KGC, based in Älvsjö, has for more than 60 years developed and delivered quality tools and accessories for bricklayers and tilers in its own brand KGC. The business has a turnover of approximately SEK 80 million per year, and has 24 employees. "KGC is a leading brand with high reputation among bricklayers and tilers and has a very strong position in the Swedish market," says Pontus Boman, President and CEO. The closing is taking effect on 1 May 2019 and the acquisition is expected to have a marginal positive impact on Bergman & Beving's earnings per share during the current fiscal year. Stockholm, 10 April 2019 Bergman & Beving AB (publ) For further information, please contact: Pontus Boman, President & CEO, Tel: +46 10 454 77 00 Peter Schön, CFO, Tel: +46 70 339 89 99 The information was submitted for publication, through the agency of the cont
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum